Charles Schwab Investment Management Inc Collegium Pharmaceutical, Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 367,406 shares of COLL stock, worth $11.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
367,406
Previous 381,494
3.69%
Holding current value
$11.2 Million
Previous $14.7 Million
28.59%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding COLL
# of Institutions
248Shares Held
37.5MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$177 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$80.4 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$69.7 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$65.4 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$50.5 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.04B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...